Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Use of Higher Versus Lower Oxygen Concentration Improve Neurodevelopmental Outcomes at 18-24 Months in Very Low Birthweight Infants - The HiLo-Trial

NCT03825835 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.

NCT NCT03825835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03825835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Use of Higher Versus Lower Oxygen Concentration Improve Neurodevelopmental Outcomes at 18-24 Months in Very Low Birthweight Infants - The HiLo-Trial
Lead sponsor
University of Alberta
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 27, 2022
Completion date
December 30, 2029
Enrollment
1,203 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

neurodevelopmental outcome, premature infant, respiratory distress syndrome in premature infant